A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made "exciting," patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors.

News Medical

United States

Non-toxic bacterial therapy shows promise for targeting tumors

A University of Massachusetts Amherst-Ernest Pharmaceuticals team of scientists has made "exciting," patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds promise for very safe and more effective treatment of cancers with high mortality rates, including liver, ovarian and metastatic breast cancer.

Medical Xpress

Research using non-toxic bacteria to fight high-mortality cancers prepares for clinical trials

Ad Fontes Media

Media Bias/Fact Check

Ian Birkby

Scientists have made 'exciting,' patient-friendly advances in developing a non-toxic bacterial therapy, BacID, to deliver cancer-fighting drugs directly into tumors. This emerging technology holds promise for very safe and more effective treatment of cancers with high mortality rates, including liver, ovarian and metastatic breast cancer.

All Sides

Science Daily

Daniel Hogan

For men, particularly those who are getting on in years, the fear of getting prostate cancer looms large. With prostate cancer being the second most common cancer for men in the United States, and with over 160,000 new diagnoses each year, their fears are certainly not groundless. Although the prognosis for men diagnosed early is good, prostate cancer still claims over 26,000 lives each year. A new study conducted by researchers from University …

Dr. Eddy Bettermann MD

Light therapy found to destroy prostate cancer in new clinical trial

A new frontier in cancer therapy is emerging from the collaborative efforts of scientists at the University of Massachusetts Amherst and Ernest Pharmaceuticals. Their research focuses on a novel non-toxic bacterial treatment, referred to as BacID, designed to enhance the delivery of cancer-fighting drugs directly into tumors. Unlike conventional chemotherapy, which often subjects patients to harsh side effects, this innovative approach aims to p…

Non-toxic bacterial therapy shows promise for targeting tumors

Coverage Details

Bias Distribution

Ownership

Similar News Topics

Similar News Topics